$261 Million is the total value of JW Asset Management, LLC's 8 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 50.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ESTA | ESTABLISHMENT LABS HLDGS INC | $216,258,934 | +3.2% | 3,192,485 | 0.0% | 83.00% | -3.8% | |
| NVO | Buy | NOVO-NORDISK A Sadr | $9,405,174 | +56.2% | 59,100 | +32.8% | 3.61% | +45.7% |
| CPRX | CATALYST PHARMACEUTICALS INC | $9,341,039 | -10.9% | 563,392 | 0.0% | 3.58% | -16.8% | |
| LLY | New | LILLY ELI & CO | $9,272,340 | – | 27,000 | +100.0% | 3.56% | – |
| CELH | CELSIUS HLDGS INC | $7,996,372 | -10.7% | 86,038 | 0.0% | 3.07% | -16.7% | |
| HZNP | HORIZON THERAPEUTICS PUB L | $5,530,451 | -4.1% | 50,673 | 0.0% | 2.12% | -10.6% | |
| New | FAZE HOLDINGS INC | $1,437,794 | – | 3,126,319 | +100.0% | 0.55% | – | |
| Buy | IDAHO STRATEGIC RESOURCES | $1,323,164 | +6.9% | 271,697 | +25.1% | 0.51% | -0.2% | |
| MSACW | Exit | MEDICUS SCIENCES ACQUISITION*w exp 02/12/202 | $0 | – | -11,110 | -100.0% | 0.00% | – |
| MSAC | Exit | MEDICUS SCIENCES ACQUISITION | $0 | – | -100,000 | -100.0% | -0.41% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-05
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMAZON COM INC COM | 30 | Q1 2022 | 44.1% |
| ESTABLISHMENT LABS HLDGS INC | 21 | Q3 2023 | 92.3% |
| ANTARES PHARMA INC | 19 | Q2 2019 | 4.0% |
| EAGLE PHARMACEUTICALS INC | 18 | Q1 2019 | 28.4% |
| HORIZON PHARMA PLC | 18 | Q1 2019 | 8.2% |
| HORIZON THERAPEUTICS PUB LTD | 17 | Q2 2023 | 6.5% |
| LIGAND PHARMACEUTICALS INC SHS CL B | 17 | Q4 2018 | 3.4% |
| BIOSPECIFICS TECHNOLOGIES CO | 16 | Q1 2019 | 8.4% |
| MICROSOFT CORP | 14 | Q1 2020 | 11.1% |
| CAMBREX CORP COM | 14 | Q1 2018 | 2.6% |
View JW Asset Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| ESTABLISHMENT LABS HOLDINGS INC. | May 30, 2019 | 2,320,364 | 11.4% |
| EAGLE PHARMACEUTICALS, INC. | January 27, 2017 | 397,648 | 2.6% |
View JW Asset Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-09 |
| 4 | 2024-01-02 |
| SC 13D/A | 2024-01-02 |
| 4 | 2023-12-26 |
| 4 | 2023-12-19 |
| 4 | 2023-12-12 |
| 4 | 2023-12-07 |
| 4 | 2023-12-06 |
| 4 | 2023-11-21 |
| 4 | 2023-11-20 |
View JW Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.